Trapianto autologo di isole pancreatiche: un approccio di terapia cellulare nei soggetti sottoposti a pancreasectomia totale
Il Diabete · 30.10.2026 · 38 (3)
DOI: 10.30682/ildia2603d ↗Kurz gefasst
Fachartikel in der Zeitschrift Il Diabete, online erschienen am 30.10.2026. Verfasst von Alessandro Csermely und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Total pancreatectomy causes insulin-dependent pancreatogenic diabetes, characterised by marked glycaemic variability and unpredictable hypoglycaemia. Total pancreatectomy with islet autotransplantation (TPIAT) preserves endogenous endocrine function without immunosuppression. Although insulin independence is achieved in only a minority of recipients, partial graft function may improve glycaemic stability and reduce severe hypoglycaemia. Standardised outcome measures, improved engraftment and careful extension to selected non-pancreatitis indications are needed to consolidate its clinical role.
Zitieren
APA
Csermely, A., Trombetta, M., & Bonadonna, R. C. (2026). Trapianto autologo di isole pancreatiche: un approccio di terapia cellulare nei soggetti sottoposti a pancreasectomia totale. Il Diabete, 38(3). https://doi.org/10.30682/ildia2603d
Vancouver
Csermely A, Trombetta M, Bonadonna RC. Trapianto autologo di isole pancreatiche: un approccio di terapia cellulare nei soggetti sottoposti a pancreasectomia totale. Il Diabete. 2026;38(3). doi:10.30682/ildia2603d
BibTeX
@article{Csermely2026,
author = {Csermely, Alessandro and Trombetta, Maddalena and Bonadonna, Riccardo C.},
title = {Trapianto autologo di isole pancreatiche: un approccio di terapia cellulare nei soggetti sottoposti a pancreasectomia totale},
journal = {Il Diabete},
year = {2026},
volume = {38},
number = {3},
doi = {10.30682/ildia2603d}
}
EUVIMED